NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC rose 2%, while the Danish
In the past week, the Power2X & Fuel Cells sector skyrocketed with a 23% increase on a sector level. Many companies in the sector did
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, six companies reported financial results, Ascendis Pharma
In the past week, the Mobility and Energy Production & Storage sectors did very well – again. The best-performing stock is about to be acquired
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Gubra increased their financial outlook for 2024,
In the past week, the Mobility and Energy Production & Storage sectors did very well. The best-performing stocks were driven by Q1 results, a collaboration
In the past week, the Power2X & Fuel Cells and Waste Management sectors did very well. A license to a 2.5 GW offshore wind project,
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Genmab and Zealand Pharma received new price
In the past week, the Energy Production & Storage sector did well although it was driven by a few stocks with great performance. Only a
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full of exciting news. Genmab announced
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: CS Medica, EKOBOT AB, Biotech, Ensurge, Lifecare AS, NORD.investments, Biosergen, Hypefactors, Curasight, Re-Match, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.